Gastritis – Pipeline Review, H1 2012

Global Markets Direct
May 28, 2012
33 Pages - SKU: GMD3913769
Nerve Gas & Pestiside Poisioning - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
Nerve Gas & Pestiside Poisioning - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Nerve Gas & Pestiside Poisioning - Pipeline Review, H2 2014’, provides an overview of the Nerve Gas & Pestiside Poisioning’s therapeutic pipeline. This report  |  read more...
USD 2,000
Premature Labor (Tocolysis) - Pipeline Review, H2 2014
10/25/2014 | published by: Global Markets Direct
Premature Labor (Tocolysis) - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Premature Labor (Tocolysis) - Pipeline Review, H2 2014’, provides an overview of the Premature Labor (Tocolysis)’s therapeutic pipeline. This report provides comprehensive information on the therapeutic  |  read more...
USD 2,000
Psoriasis - Pipeline Review, H2 2014
10/30/2014 | published by: Global Markets Direct
Psoriasis - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Psoriasis - Pipeline Review, H2 2014’, provides an overview of the Psoriasis’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Psoriasis, complete with comparative  |  read more...
USD 2,000
Stroke - Pipeline Review, H2 2014
10/30/2014 | published by: Global Markets Direct
Stroke - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Stroke - Pipeline Review, H2 2014’, provides an overview of the Stroke’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Stroke, complete with comparative  |  read more...
USD 2,000
EpiCast Report: Type 1 Diabetes - Epidemiology Forecast to 2023
11/1/2014 | published by: GlobalData
EpiCast Report: Type 1 Diabetes - Epidemiology Forecast to 2023 Summary Type 1 diabetes is a type of diabetes that accounts for 10% of all diabetes cases. The condition occurs as a result of the autoimmune destruction  |  read more...
USD 3,995
EpiCast Report: Cushing’s Syndrome - Epidemiology Forecast to 2023
10/27/2014 | published by: GlobalData
EpiCast Report: Cushing’s Syndrome - Epidemiology Forecast to 2023 Summary Cushing’s syndrome (CS) is a rare disorder caused by prolonged exposure to excess amounts of circulating free glucocorticoids, such as cortisol. Cortisol is a hormone produced by  |  read more...
USD 3,995
Non-Hodgkin Lymphoma - Pipeline Review, H2 2014
10/30/2014 | published by: Global Markets Direct
Non-Hodgkin Lymphoma - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Non-Hodgkin Lymphoma - Pipeline Review, H2 2014’, provides an overview of the Non-Hodgkin Lymphoma’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Non-Hodgkin  |  read more...
USD 2,000
Myocardial Ischemia - Pipeline Review, H2 2014
10/30/2014 | published by: Global Markets Direct
Myocardial Ischemia - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Myocardial Ischemia - Pipeline Review, H2 2014’, provides an overview of the Myocardial Ischemia’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Myocardial  |  read more...
USD 2,000
EpiCast Report: Irritable Bowel Syndrome - Epidemiology Forecast to 2023
10/27/2014 | published by: GlobalData
EpiCast Report: Irritable Bowel Syndrome - Epidemiology Forecast to 2023 Summary Irritable Bowel Syndrome (IBS) is a chronic, relapsing gastrointestinal disorder that is characterized by abdominal discomfort or pain, bloating, and changes in bowel habit. Due to  |  read more...
USD 3,995
Ovarian Cancer - Pipeline Review, H2 2014
10/30/2014 | published by: Global Markets Direct
Ovarian Cancer - Pipeline Review, H2 2014 Summary Global Markets Direct’s, ‘Ovarian Cancer - Pipeline Review, H2 2014’, provides an overview of the Ovarian Cancer’s therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Ovarian  |  read more...
USD 2,500
 

SELECT A LICENSE

    Online Download  USD 500  
    Site License  USD 1,000  
    Global Site License  USD 1,500  
 
US: 800.298.5699
Int'l: +1.240.747.3093
 

Share this report


    Other tasks

     
     
    Join Alert Me now!
    Receive bi-weekly email alerts on new market research

    Sign up today!